Dangaj D, Bruand M, Grimm AJ, Ronet C, Barras D, Duttagupta PA, Lanitis E, Duraiswamy J, Tanyi JL, Benencia F, Conejo-Garcia J, Ramay HR, Montone KT, Powell DJ Jr, Gimotty PA, Facciabene A, Jackson DG, Weber JS, Rodig SJ, Hodi SF, Kandalaft LE, Irving M, Zhang L, Foukas P, Rusakiewicz S, Delorenzi M, Coukos G.: Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors. Cancer Cell : 35(6):885-900,2019.
Janos L. Tanyi, Oliver Dorigo, Amit Oza, James Strauss, Tanya Pejovic, Sharad Ghamande, Prafull Ghatage, Jeannine Villella, Stephan Fiset, Lisa D. MacDonald, Olga Hrytsenko, Marianne M. Stanford, Robert C. Newton, Lance Leopold, Gabriela Rosu: DPX-Survivac and intermittent low dose cyclophosphamide (CPA) with or without epacadostat (E) in the treatment of subjects with advanced recurrent epithelial ovarian cancer (DeCidE1 trial): T cell responses and tumor infiltration correlate with tumor regression ASCO annual meeting, May 31st to June 4th, 2019, Chicago IL : 2019.
Hu Z, Zhou J, Jiang J, Yuan J, Zhang Y, Wei X, Loo N, Wang Y, Pan Y, Zhang T, Zhong X, Long M, Montone KT, Tanyi JL, Fan Y, Wang TL, Shih IM, Hu X, Zhang L.: Genomic characterization of genes encoding histone acetylation modulator proteins identifies therapeutic targets for cancer treatment. Nat Commun. : 13;10(1):733,2019.
Tanyi JL, George E: Personalized vaccination against ovarian cancer: what are the possibilities? Expert Rev Vaccines : 17(11):955-958,2018.
Yuan J, Hu Z, Mahal BA, Zhao SD, Kensler KH, Pi J, Hu X, Zhang Y, Wang Y, Jiang J, Li C, Zhong X, Montone KT, Guan G, Tanyi JL, Fan Y, Xu X, Morgan MA, Long M, Zhang Y, Zhang R, Sood AK, Rebbeck TR, Dang CV, Zhang L: Integrated Analysis of Genetic Ancestry and Genomic Alterations across Cancers. Cancer Cell : 8;34(4):549-560,2018.
Leslie M. Randall MD, Robert M. Wenham MD, Philip S. Low PhD, Sean C. Dowdy MD, Mark A. Morgan MD, Janos L. Tanyi MD, PhD: A phase 2, single-dose, open-label study to investigate the safety and efficacy of OTL 38 injection (OTL38) for intraoperative imaging during cytoreductive surgery for ovarian cancer Society of Pelvic Surgeons Annual Meeting, September 24th to 29th, 2018. Bucharest, Brasov, Romania : 2018.
Janos L. Tanyi: Ovarian cancer Immunotherapy Oxford University Press (Chapter 8): 2018.
Lin X, Shen J, Dan Peng, He X, Xu C, Chen X, Tanyi JL, Montone K, Fan Y, Huang Q, Zhang L, Zhong X: RNA-binding protein LIN28B inhibits apoptosis through regulation of the AKT2/FOXO3A/BIM axis in ovarian cancer cells. Signal Transduct Target Ther. : 31;3:23,2018.
Lorenzo Ramirez, A. T. Charlie Johnson, Cindy Otto, Janos Laszlo Tanyi, Jody Piltz-Seymour, Jae Hyock Kwak, Katharine Prigg, Nicholas Kybert, George Preti; California Lutheran University, Thousand Oaks, CA; University of Pennsylvania Department of Physics & Astronomy, Philadelphia, PA; University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA; University of Pennsylvania, Philadlephia, PA; University of Pennsylvania Perelman School of Medicine, Narberth, PA; Global Spectroscopy 2, Teterboro: Exploring ovarian cancer detection using an interdisciplinary investigation of its volatile odor signature 2018 ASCO Annual Meeting, Chicago, : 2018.
Katsnelson M, Hwang WT, Tahirovic E, Rubin SC, Tanyi JL.: Preoperative predictors that impact the survival and outcome of patients undergoing secondary cytoreduction for ovarian cancer. J Obstet Gynaecol : 38(3):395-401,2018.